Pancreatic Cancer Disease – Global Clinical Trials Review, H1 2020

GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Pancreatic Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Bristol-Myers Squibb Co

F. Hoffmann-La Roche Ltd

Novartis AG

Pfizer Inc

AstraZeneca Plc

Eli Lilly and Co

Sanofi

Merck & Co Inc

Otsuka Holdings Co Ltd

GlaxoSmithKline Plc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 21

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 25

In Progress Trials by Phase 26

Clinical Trials by Trial Status 27

Clinical Trials by End Point Status 29

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials 34

Prominent Drugs 36

Latest Clinical Trials News on Pancreatic Cancer 37

Nov 26, 2019: Soricimed announces Journal of Cancer publication identifying TRPV6 as a promising target for cancer therapy 37

Nov 25, 2019: TYME to ring Nasdaq opening bell on November 27 to honor all stakeholders committed to finding a cure for patients with Pancreatic Cancer 37

Nov 25, 2019: PharmaCyte Biotech “Release Testing” successful on all completed tests of clinical trial product 37

Nov 18, 2019: Cantargia presents novel preclinical data on antibody CAN04 at PEGS Europe conference 38

Nov 15, 2019: Cantargia advance antibody CAN04 development after positive pre-IND meeting 38

Nov 13, 2019: Moleculin announces beginning of preclinical development of new approach to pancreatic cancer 39

Nov 11, 2019: Cancer Advances announces a new publication “Vaccine Against Gastrin, a Polyclonal Antibody Stimulator, Decreases Pancreatic Cancer Metastases” in the American Journal of Physiology—Gastrointestinal and Liver Physiology 39

Nov 11, 2019: ORYX confirms ParvOryx mode of action in tumor explant model 39

Nov 07, 2019: NanOlogy clinical updates on local injection of NanoPac for Pancreatic Cancer and Mucinous Cystic Neoplasms of the Pancreas 40

Clinical Trial Profile Snapshots 41

Appendix 2247

Abbreviations 2247

Definitions 2247

Research Methodology 2248

Secondary Research 2248

About GlobalData 2249

Contact Us 2249

Disclaimer 2249

Source 2250

List of Tables

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2020* 8

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 10

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 12

Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 13

Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2020* 14

Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020* 15

Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 16

Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2020* 17

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 20

Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2020* 21

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 22

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 24

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2020* 25

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 26

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020* 28

Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020* 29

Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 30

Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 31

Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 33

Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 35

Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 36

List of Figures

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2020* 8

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020* 12

Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020* 13

Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2020* 14

Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020* 15

Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020* 16

Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2020* 17

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 19

Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2020* 21

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 22

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 23

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2020* 25

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2020* 26

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020* 27

Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020* 29

Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 30

Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020* 31

Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 32

Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 34

Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 36

GlobalData Methodology 2248

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports